New drug trial targets debilitating endometriosis pain
Disease control
Not yet recruiting
This study aims to see if an investigational drug called HMI-115 can safely reduce moderate to severe pain caused by endometriosis. It will involve about 540 women who will receive either the drug or a placebo for 24 weeks, with an option to continue for another 28 weeks. The mai…
Phase: PHASE3 • Sponsor: Hope Medicine (Nanjing) Co., Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC